Medicinal Chemistry, Oncology CEDD, GlaxoSmithKline, 1250 S. Collegeville Road, Collegeville, PA 19426, United States
Abstract:
Two regioselective synthetic routes for 1-N-alkyl-3-aryl-4-pyrimidin-4-yl]-pyrazoles of generic formula 1 were developed. These highly efficient and scalable routes circumvent the generally observed poor regioselectivity for the pyrazole alkylation.